864 related articles for article (PubMed ID: 16759051)
21. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
22. Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.
Kirk O; Gatell JM; Mocroft A; Pedersen C; Proenca R; Brettle RP; Barton SE; Sudre P; Phillips AN
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):865-72. PubMed ID: 10988097
[TBL] [Abstract][Full Text] [Related]
23. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
Lange CG; Woolley IJ; Brodt RH
Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
[TBL] [Abstract][Full Text] [Related]
24. Mycobacterium avium complex infection in HIV/AIDS patients.
Corti M; Palmero D
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):351-63. PubMed ID: 18588499
[TBL] [Abstract][Full Text] [Related]
25. Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents.
Cinti SK; Kaul DR; Sax PE; Crane LR; Kazanjian PH
Clin Infect Dis; 2000 Mar; 30(3):511-4. PubMed ID: 10722436
[TBL] [Abstract][Full Text] [Related]
26. Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.
Rossi M; Flepp M; Telenti A; Schiffer V; Egloff N; Bucher H; Vernazza P; Bernasconi E; Weber R; Rickenbach M; Furrer H;
Swiss Med Wkly; 2001 Aug; 131(31-32):471-7. PubMed ID: 11641970
[TBL] [Abstract][Full Text] [Related]
27. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA
J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752
[TBL] [Abstract][Full Text] [Related]
28. Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects.
Havlir DV; Schrier RD; Torriani FJ; Chervenak K; Hwang JY; Boom WH
J Infect Dis; 2000 Dec; 182(6):1658-63. PubMed ID: 11069237
[TBL] [Abstract][Full Text] [Related]
29. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
[TBL] [Abstract][Full Text] [Related]
30. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
31. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
[TBL] [Abstract][Full Text] [Related]
32. Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study.
Sterling TR; Chaisson RE; Keruly J; Moore RD
J Infect Dis; 2003 Dec; 188(11):1659-65. PubMed ID: 14639536
[TBL] [Abstract][Full Text] [Related]
33. Mastitis due to Mycobacterium avium complex in an HIV-infected woman taking highly active antiretroviral therapy.
Cunningham CO; Selwyn PA
AIDS Patient Care STDS; 2003 Nov; 17(11):547-50. PubMed ID: 14746662
[TBL] [Abstract][Full Text] [Related]
34. Initiation of highly active antiretroviral therapy in advanced AIDS with CD4 < 50 cells/mm3 in a resource-limited setting: efficacy and tolerability.
Sungkanuparph S; Kiertiburanakul S; Manosuthi W; Kiatatchasai W; Vibhagool A
Int J STD AIDS; 2005 Mar; 16(3):243-6. PubMed ID: 15829026
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
Shirasaka T
Kekkaku; 2007 Nov; 82(11):845-8. PubMed ID: 18078110
[TBL] [Abstract][Full Text] [Related]
36. Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.
Toulson AR; Harrigan R; Heath K; Yip B; Brumme ZL; Harris M; Hogg RS; Montaner JS
J Infect Dis; 2005 Nov; 192(10):1787-93. PubMed ID: 16235178
[TBL] [Abstract][Full Text] [Related]
37. A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patients.
Piroth L; Fournel I; Mahy S; Yazdanpanah Y; Rey D; Rabaud C; Faller JP; Hoen B; Fardeheb M; Quantin C; Chavanet P; Binquet C;
Epidemiol Infect; 2011 Dec; 139(12):1835-44. PubMed ID: 21232172
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.
Fernández Guerrero ML; Rivas P; Molina M; Garcia R; De Górgolas M
Clin Infect Dis; 2005 Aug; 41(3):390-4. PubMed ID: 16007538
[TBL] [Abstract][Full Text] [Related]
39. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.
Madec Y; Laureillard D; Pinoges L; Fernandez M; Prak N; Ngeth C; Moeung S; Song S; Balkan S; Ferradini L; Quillet C; Fontanet A
AIDS; 2007 Jan; 21(3):351-9. PubMed ID: 17255742
[TBL] [Abstract][Full Text] [Related]
40. Impact of disseminated Mycobacterium avium-complex infection on survival of HIV-infected patients.
Brodt HR; Enzensberger R; Kamps BS; Keul HG; Helm EB
Eur J Med Res; 1997 Mar; 2(3):106-10. PubMed ID: 9113499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]